Authors:
Yau, JC
Gertler, SZ
Hanson, J
Verma, S
Grimard, LJ
Malik, ST
Aref, IM
Cross, PW
Tomiak, EM
Stewart, DJ
St Cyr, DA
Huan, SD
Citation: Jc. Yau et al., A phase III study of high-dose intensification without hematopoietic progenitor cells support for patients with high-risk primary breast carcinoma, AM J CL ONC, 23(3), 2000, pp. 292-296
Authors:
Stewart, DJ
Goel, R
Gertler, SZ
Huan, S
Tomiak, EM
Yau, J
Cripps, C
Evans, WK
Citation: Dj. Stewart et al., Concurrent use of multiple low dose chemotherapy agents with differing mechanisms of action as a strategy vs passive resistance: A pilot study, INT J ONCOL, 15(4), 1999, pp. 693-699
Authors:
Nabholtz, JM
Senn, HJ
Bezwoda, WR
Melnychuk, D
Deschenes, L
Douma, J
Vandenberg, TA
Rapoport, B
Rosso, R
Trillet-Lenoir, V
Drbal, J
Molino, A
Nortier, JWR
Richel, DJ
Nagykalnai, T
Siedlecki, P
Wilking, N
Genot, JY
Hupperets, PSGJ
Pannuti, F
Skarlos, D
Tomiak, EM
Murawsky, M
Alakl, M
Riva, A
Aapro, M
Citation: Jm. Nabholtz et al., Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy, J CL ONCOL, 17(5), 1999, pp. 1413-1424
Authors:
Will, BP
Le Petit, C
Berthelot, JM
Tomiak, EM
Verma, S
Evans, WK
Citation: Bp. Will et al., Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs, BR J CANC, 79(9-10), 1999, pp. 1428-1436